Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China

Background and purpose We aimed to determine whether young adults (<50 years) with acute ischaemic stroke (AIS) are more likely to receive intravenous tissue plasminogen activator (IV tPA) and have shorter time to treatment than older patients with stroke.Methods We analysed data from the Chi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yong-Jun Wang, Xin Yang, Qi Zhou, Hao Li, Xia Meng, Yong Jiang, Li-Ping Liu, Yi-long Wang, Hong-Qiu Gu, Zi-Xiao Li, Xing-Quan Zhao, Chun-Juan Wang, Chelsea Liu, Hai-yan Wang, Ying-Yu Jiang
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e055055.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587254596370432
author Yong-Jun Wang
Xin Yang
Qi Zhou
Hao Li
Xia Meng
Yong Jiang
Li-Ping Liu
Yi-long Wang
Hong-Qiu Gu
Zi-Xiao Li
Xing-Quan Zhao
Chun-Juan Wang
Chelsea Liu
Hai-yan Wang
Ying-Yu Jiang
author_facet Yong-Jun Wang
Xin Yang
Qi Zhou
Hao Li
Xia Meng
Yong Jiang
Li-Ping Liu
Yi-long Wang
Hong-Qiu Gu
Zi-Xiao Li
Xing-Quan Zhao
Chun-Juan Wang
Chelsea Liu
Hai-yan Wang
Ying-Yu Jiang
author_sort Yong-Jun Wang
collection DOAJ
description Background and purpose We aimed to determine whether young adults (<50 years) with acute ischaemic stroke (AIS) are more likely to receive intravenous tissue plasminogen activator (IV tPA) and have shorter time to treatment than older patients with stroke.Methods We analysed data from the Chinese Stroke Center Alliance registry for patients with AIS hospitalised between August 2015 and July 2019. Patients were classified into two groups according to age: young adults (<50 years of age) and older adults (≥50 years of age).Results Of 793 175 patients with AIS admitted to 1471 hospitals, 9.1% (71 860) were young adults. Compared with older adults, a higher proportion of young adults received IV tPA among patients without contraindicaitons (7.2% vs 6.1%, adjusted OR (aOR) 1.13, 95% CI 1.10 to 1.17) and among patients without contraindications and with onset-to-door time ≤3.5 hours (23.6% vs 19.3%, aOR 1.20, 95% CI 1.15 to 1.24). We did not observe differences in onset-to-needle time (median hours 2.7 hours) or door-to-needle time (DNT) (median minutes 60 min) between young and older adults. The proportion of DNT ≤30 min, DNT ≤45 min and DNT ≤60 min in young and older IV tPA-treated patients were 16.9% vs 18.8%, 30.2% vs 32.8% and 50.2% vs 54.2%, respectively. Compared with older adults, young adults treated with IV tPA had lower odds of in-hospital mortality (0.5% vs 1.3%, aOR 0.54, 95% CI 0.35 to 0.82) and higher odds of independent ambulation at discharge (61.0% vs 53.6%, aOR 1.15, 95% CI 1.08 to 1.22), and the associations may be partly explained by stroke severity measured by the National Institutes of Health Stroke Scale score.Conclusion Young adults with AIS were more likely to receive IV tPA than older adults, although there was no difference between the two groups in time to treatment. Compared with older adults, young adults may had better in-hospital outcomes.
format Article
id doaj-art-e367466c29b14250822617c4d15332f3
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-e367466c29b14250822617c4d15332f32025-01-24T16:45:15ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-055055Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in ChinaYong-Jun Wang0Xin Yang1Qi Zhou2Hao Li3Xia Meng4Yong Jiang5Li-Ping Liu6Yi-long Wang7Hong-Qiu Gu8Zi-Xiao Li9Xing-Quan Zhao10Chun-Juan Wang11Chelsea Liu12Hai-yan Wang13Ying-Yu Jiang142 China National Clinical Research centre for Neurological Diseases, Beijing, China1 School of Nursing, Jinan University, Guangzhou, Guangdong, ChinaNursing Department, Hangzhou Normal University, Hangzhou, Zhejiang, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing, China2 China National Clinical Research centre for Neurological Diseases, Beijing, China2 China National Clinical Research centre for Neurological Diseases, Beijing, China1 China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China8 Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, Massachusetts, USADepartment of Neurology and Psychiatry, Beijing Shijitan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaBackground and purpose We aimed to determine whether young adults (<50 years) with acute ischaemic stroke (AIS) are more likely to receive intravenous tissue plasminogen activator (IV tPA) and have shorter time to treatment than older patients with stroke.Methods We analysed data from the Chinese Stroke Center Alliance registry for patients with AIS hospitalised between August 2015 and July 2019. Patients were classified into two groups according to age: young adults (<50 years of age) and older adults (≥50 years of age).Results Of 793 175 patients with AIS admitted to 1471 hospitals, 9.1% (71 860) were young adults. Compared with older adults, a higher proportion of young adults received IV tPA among patients without contraindicaitons (7.2% vs 6.1%, adjusted OR (aOR) 1.13, 95% CI 1.10 to 1.17) and among patients without contraindications and with onset-to-door time ≤3.5 hours (23.6% vs 19.3%, aOR 1.20, 95% CI 1.15 to 1.24). We did not observe differences in onset-to-needle time (median hours 2.7 hours) or door-to-needle time (DNT) (median minutes 60 min) between young and older adults. The proportion of DNT ≤30 min, DNT ≤45 min and DNT ≤60 min in young and older IV tPA-treated patients were 16.9% vs 18.8%, 30.2% vs 32.8% and 50.2% vs 54.2%, respectively. Compared with older adults, young adults treated with IV tPA had lower odds of in-hospital mortality (0.5% vs 1.3%, aOR 0.54, 95% CI 0.35 to 0.82) and higher odds of independent ambulation at discharge (61.0% vs 53.6%, aOR 1.15, 95% CI 1.08 to 1.22), and the associations may be partly explained by stroke severity measured by the National Institutes of Health Stroke Scale score.Conclusion Young adults with AIS were more likely to receive IV tPA than older adults, although there was no difference between the two groups in time to treatment. Compared with older adults, young adults may had better in-hospital outcomes.https://bmjopen.bmj.com/content/12/6/e055055.full
spellingShingle Yong-Jun Wang
Xin Yang
Qi Zhou
Hao Li
Xia Meng
Yong Jiang
Li-Ping Liu
Yi-long Wang
Hong-Qiu Gu
Zi-Xiao Li
Xing-Quan Zhao
Chun-Juan Wang
Chelsea Liu
Hai-yan Wang
Ying-Yu Jiang
Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China
BMJ Open
title Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China
title_full Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China
title_fullStr Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China
title_full_unstemmed Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China
title_short Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China
title_sort thrombolysis time to treatment and in hospital outcomes among young adults with ischaemic stroke in china findings from a nationwide registry study in china
url https://bmjopen.bmj.com/content/12/6/e055055.full
work_keys_str_mv AT yongjunwang thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT xinyang thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT qizhou thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT haoli thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT xiameng thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT yongjiang thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT lipingliu thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT yilongwang thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT hongqiugu thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT zixiaoli thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT xingquanzhao thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT chunjuanwang thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT chelsealiu thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT haiyanwang thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina
AT yingyujiang thrombolysistimetotreatmentandinhospitaloutcomesamongyoungadultswithischaemicstrokeinchinafindingsfromanationwideregistrystudyinchina